As Mohawk Inds (MHK) Market Value Declined, Shareholder Columbus Circle Investors Has Cut Its Stake by $529,100; Esperion Therapeutics (ESPR) Holder Bb Biotech Ag Has Boosted Position

May 22, 2018 - By Winifred Garcia

Mohawk Industries, Inc. (NYSE:MHK) Logo

Bb Biotech Ag increased its stake in Esperion Therapeutics Inc. (ESPR) by 12.63% based on its latest 2017Q4 regulatory filing with the SEC. Bb Biotech Ag bought 265,000 shares as the company’s stock rose 22.41% while stock markets declined. The institutional investor held 2.36 million shares of the health care company at the end of 2017Q4, valued at $155.58 million, up from 2.10 million at the end of the previous reported quarter. Bb Biotech Ag who had been investing in Esperion Therapeutics Inc. for a number of months, seems to be bullish on the $1.02B market cap company. The stock decreased 10.09% or $4.25 during the last trading session, reaching $37.89. About 1.88M shares traded or 51.28% up from the average. Esperion Therapeutics, Inc. (NASDAQ:ESPR) has risen 89.86% since May 22, 2017 and is uptrending. It has outperformed by 78.31% the S&P500.

Donald Chiboucis decreased its stake in Mohawk Inds Inc (MHK) by 1.56% based on its latest 2017Q4 regulatory filing with the SEC. Columbus Circle Investors sold 1,924 shares as the company’s stock declined 17.56% with the market. The hedge fund run by Donald Chiboucis held 121,204 shares of the consumer durables company at the end of 2017Q4, valued at $33.44M, down from 123,128 at the end of the previous reported quarter. Columbus Circle Investors who had been investing in Mohawk Inds Inc for a number of months, seems to be less bullish one the $16.12 billion market cap company. The stock decreased 0.01% or $0.03 during the last trading session, reaching $216.12. About 1.11M shares traded or 29.75% up from the average. Mohawk Industries, Inc. (NYSE:MHK) has risen 0.12% since May 22, 2017 and is uptrending. It has underperformed by 11.43% the S&P500.

Among 19 analysts covering Esperion Therapeutics (NASDAQ:ESPR), 10 have Buy rating, 3 Sell and 6 Hold. Therefore 53% are positive. Esperion Therapeutics had 68 analyst reports since July 28, 2015 according to SRatingsIntel. The firm has “Neutral” rating given on Friday, February 26 by Chardan Capital Markets. The firm has “Buy” rating by Cowen & Co given on Wednesday, October 18. The firm has “Buy” rating by Jefferies given on Monday, March 19. The stock of Esperion Therapeutics, Inc. (NASDAQ:ESPR) earned “Buy” rating by Northland Capital on Thursday, April 19. As per Wednesday, June 29, the company rating was downgraded by Barclays Capital. The company was downgraded on Wednesday, May 2 by Bank of America. Stifel Nicolaus maintained it with “Buy” rating and $64 target in Thursday, February 25 report. As per Wednesday, March 7, the company rating was maintained by Cowen & Co. The firm earned “Neutral” rating on Wednesday, February 21 by JP Morgan. The company was maintained on Wednesday, March 9 by JMP Securities.

Investors sentiment decreased to 1.33 in Q4 2017. Its down 0.34, from 1.67 in 2017Q3. It worsened, as 19 investors sold ESPR shares while 39 reduced holdings. 33 funds opened positions while 44 raised stakes. 22.69 million shares or 0.18% less from 22.73 million shares in 2017Q3 were reported. Gp One Trading LP owns 4,841 shares. Keybank Natl Association Oh has invested 0% in Esperion Therapeutics, Inc. (NASDAQ:ESPR). Pub Employees Retirement System Of Ohio holds 0.01% in Esperion Therapeutics, Inc. (NASDAQ:ESPR) or 29,555 shares. Pictet Asset Mngmt Limited reported 343,393 shares. Ameriprise stated it has 25,234 shares. Atika Mngmt Ltd Liability has invested 1.43% in Esperion Therapeutics, Inc. (NASDAQ:ESPR). Geode Cap Mgmt Ltd Llc holds 0% or 174,080 shares in its portfolio. Victory Cap Mngmt Incorporated has invested 0% in Esperion Therapeutics, Inc. (NASDAQ:ESPR). Prelude Mngmt Ltd Co accumulated 500 shares. Partner Invest Limited Partnership owns 12,140 shares or 0.92% of their US portfolio. Moreover, Macquarie Gru has 0% invested in Esperion Therapeutics, Inc. (NASDAQ:ESPR). C Ww Wide A S has invested 0% in Esperion Therapeutics, Inc. (NASDAQ:ESPR). The New York-based Millennium Lc has invested 0.04% in Esperion Therapeutics, Inc. (NASDAQ:ESPR). Parkside Bancorporation & reported 0.02% in Esperion Therapeutics, Inc. (NASDAQ:ESPR). Toth Financial Advisory accumulated 30 shares.

More notable recent Esperion Therapeutics, Inc. (NASDAQ:ESPR) news were published by: Schaeffersresearch.com which released: “3 Drug Stocks Near the Bottom of the Nasdaq Today” on May 02, 2018, also Globenewswire.com with their article: “ESPR SHAREHOLDER ALERT: The Law Offices of Vincent Wong Notifies Investors of Commencement of a Class …” published on May 18, 2018, Globenewswire.com published: “DEADLINE ALERT: Shareholder Class Action Lawsuit Filed Against Esperion Therapeutics, Inc. – ESPR” on May 14, 2018. More interesting news about Esperion Therapeutics, Inc. (NASDAQ:ESPR) were released by: Nasdaq.com and their article: “3 Top Healthcare Stocks to Buy Right Now” published on May 01, 2018 as well as Nasdaq.com‘s news article titled: “Here’s Why Esperion Therapeutics Inc. Stock Is Bouncing Back Today” with publication date: May 04, 2018.

Bb Biotech Ag, which manages about $3.55 billion US Long portfolio, decreased its stake in Agios Pharmaceuticals Inc. (NASDAQ:AGIO) by 30,000 shares to 2.72M shares, valued at $155.50 million in 2017Q4, according to the filing. It also reduced its holding in Alnylam Pharmaceuticals Inc. (NASDAQ:ALNY) by 60,000 shares in the quarter, leaving it with 1.05 million shares, and cut its stake in Juno Therapeutics Inc. (NASDAQ:JUNO).

Among 21 analysts covering Mohawk (NYSE:MHK), 16 have Buy rating, 0 Sell and 5 Hold. Therefore 76% are positive. Mohawk had 56 analyst reports since August 10, 2015 according to SRatingsIntel. On Monday, February 12 the stock rating was maintained by Robert W. Baird with “Outperform”. The stock of Mohawk Industries, Inc. (NYSE:MHK) earned “Neutral” rating by JP Morgan on Tuesday, May 1. The firm earned “Buy” rating on Tuesday, November 14 by RBC Capital Markets. On Monday, November 9 the stock rating was maintained by RBC Capital Markets with “Outperform”. The stock of Mohawk Industries, Inc. (NYSE:MHK) earned “Buy” rating by Goldman Sachs on Tuesday, October 6. On Monday, February 12 the stock rating was maintained by Jefferies with “Buy”. The rating was initiated by Topeka Capital Markets on Tuesday, May 24 with “Hold”. On Friday, April 27 the stock rating was maintained by Loop Capital Markets with “Hold”. The rating was maintained by Robert W. Baird on Monday, November 20 with “Buy”. The rating was maintained by Credit Suisse with “Outperform” on Friday, April 27.

Since February 14, 2018, it had 4 insider buys, and 11 sales for $12.15 million activity. The insider Boykin Frank H sold $344,580. Another trade for 500 shares valued at $125,435 was made by RUNGE WILLIAM HENRY III on Wednesday, February 14. 446 shares valued at $109,270 were sold by Patton Rodney David on Friday, March 9. Thiers Bernard also sold $4.35 million worth of Mohawk Industries, Inc. (NYSE:MHK) on Tuesday, February 20. WELLBORN CHISTOPHER also sold $2.19M worth of Mohawk Industries, Inc. (NYSE:MHK) on Friday, February 16. $5.44 million worth of Mohawk Industries, Inc. (NYSE:MHK) shares were bought by BALCAEN FILIP.

Investors sentiment increased to 1.13 in 2017 Q4. Its up 0.03, from 1.1 in 2017Q3. It increased, as 28 investors sold MHK shares while 181 reduced holdings. 74 funds opened positions while 163 raised stakes. 56.08 million shares or 0.46% more from 55.82 million shares in 2017Q3 were reported. Meiji Yasuda Asset Mgmt Com reported 0.12% of its portfolio in Mohawk Industries, Inc. (NYSE:MHK). Retirement System Of Alabama, a Alabama-based fund reported 30,622 shares. Jefferies Group Incorporated Limited stated it has 0.02% of its portfolio in Mohawk Industries, Inc. (NYSE:MHK). Sei Invests owns 0.01% invested in Mohawk Industries, Inc. (NYSE:MHK) for 14,041 shares. Fin Architects accumulated 0.01% or 301 shares. Pillar Pacific Llc holds 0.06% or 1,785 shares in its portfolio. United Automobile Association stated it has 21,582 shares. Cubist Systematic Strategies Ltd Liability has 3,991 shares. Comerica Commercial Bank has 0.03% invested in Mohawk Industries, Inc. (NYSE:MHK) for 16,404 shares. Quantitative Investment Management Lc has invested 0.2% in Mohawk Industries, Inc. (NYSE:MHK). National Bank Of Montreal Can holds 92,567 shares or 0.02% of its portfolio. Wilbanks Smith And Thomas Asset Management Limited Com invested in 0.03% or 1,518 shares. Credit Agricole S A reported 24,087 shares. Banque Pictet Cie Sa holds 0.02% of its portfolio in Mohawk Industries, Inc. (NYSE:MHK) for 2,738 shares. Amundi Pioneer Asset Mngmt accumulated 109,535 shares.

Analysts await Mohawk Industries, Inc. (NYSE:MHK) to report earnings on July, 26. They expect $3.96 earnings per share, up 6.45% or $0.24 from last year’s $3.72 per share. MHK’s profit will be $295.41M for 13.64 P/E if the $3.96 EPS becomes a reality. After $3.01 actual earnings per share reported by Mohawk Industries, Inc. for the previous quarter, Wall Street now forecasts 31.56% EPS growth.

Esperion Therapeutics, Inc. (NASDAQ:ESPR) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


>